- £937.01m
- £951.41m
- £472.60m
- 83
- 31
- 93
- 82
Annual income statement for Chemring, fiscal year end - October 31st, GBP millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | R2022 October 31st | 2023 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 335 | 403 | 393 | 401 | 473 |
| Cost of Revenue | |||||
| Gross Profit | 117 | 128 | 119 | 111 | 150 |
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 304 | 356 | 343 | 352 | 427 |
| Operating Profit | 31.3 | 46.3 | 50.4 | 49.4 | 45.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 26.7 | 43.3 | 48.8 | 47.9 | 44.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 23.1 | 34.7 | 41.5 | 44.4 | 37.7 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 21.9 | 34.7 | 41.5 | 47.4 | 5.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 21.9 | 34.7 | 41.5 | 47.4 | 5.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.083 | 0.123 | 0.148 | 0.158 | 0.221 |
| Dividends per Share |